Tags

Type your tag names separated by a space and hit enter

Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
Indian J Lepr. 1984 Jan-Mar; 56(1):78-85.IJ

Abstract

Rifampicin, Clofazimine and D.D.S. have been tried in fifteen active untreated lepromatous cases for a period of two years. Compared to dapsone monotherapy remarkable clinical and bacteriological improvement was observed with this combined therapy with attainment of negative BI in ten cases. Use of this combination therapy is thus advocated to achieve noninfectivity in a shorter period and to prevent emergence of dapsone resistance thereby causing the path of leprosy control before it becomes unmanageable due to dapsone resistance.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

6548246

Citation

Kundu, S K., et al. "Evaluation of Multidrug Therapy With Rifampicin, Clofazimine and D.D.S. in Multibacillary Leprosy Cases." Indian Journal of Leprosy, vol. 56, no. 1, 1984, pp. 78-85.
Kundu SK, Hazra SK, Chaudhury S, et al. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases. Indian J Lepr. 1984;56(1):78-85.
Kundu, S. K., Hazra, S. K., Chaudhury, S., & Chatterjee, B. (1984). Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases. Indian Journal of Leprosy, 56(1), 78-85.
Kundu SK, et al. Evaluation of Multidrug Therapy With Rifampicin, Clofazimine and D.D.S. in Multibacillary Leprosy Cases. Indian J Lepr. 1984 Jan-Mar;56(1):78-85. PubMed PMID: 6548246.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases. AU - Kundu,S K, AU - Hazra,S K, AU - Chaudhury,S, AU - Chatterjee,B, PY - 1984/1/1/pubmed PY - 1984/1/1/medline PY - 1984/1/1/entrez SP - 78 EP - 85 JF - Indian journal of leprosy JO - Indian J Lepr VL - 56 IS - 1 N2 - Rifampicin, Clofazimine and D.D.S. have been tried in fifteen active untreated lepromatous cases for a period of two years. Compared to dapsone monotherapy remarkable clinical and bacteriological improvement was observed with this combined therapy with attainment of negative BI in ten cases. Use of this combination therapy is thus advocated to achieve noninfectivity in a shorter period and to prevent emergence of dapsone resistance thereby causing the path of leprosy control before it becomes unmanageable due to dapsone resistance. SN - 0254-9395 UR - https://www.unboundmedicine.com/medline/citation/6548246/Evaluation_of_multidrug_therapy_with_rifampicin_clofazimine_and_D_D_S__in_multibacillary_leprosy_cases_ L2 - https://medlineplus.gov/mycobacterialinfections.html DB - PRIME DP - Unbound Medicine ER -